Marty Makary

Marty Makary is the commissioner of the Food and Drug Administration (FDA) under President Donald Trump, as indicated by multiple news articles. He is newsworthy due to several recent events and controversies within the agency. One article mentions internal memos revealing scant data behind changes to Covid vaccine recommendations, raising questions about the basis for these decisions. Another reports the FDA's approval of a generic drug for a rare brain disorder, while another details the second departure of FDA vaccine chief Vinay Prasad under Makary's leadership. Further, the FDA, under Makary, is proposing a new system for approving customized drugs for rare diseases and relaxing rules on 'no artificial colors' claims on food products. The potential retirement of a top drug regulator adds to the agency's turmoil, highlighting the challenges Makary faces in maintaining stability and navigating political pressures within the FDA.